Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Feb 1;146(3):850-860.
doi: 10.1002/ijc.32354. Epub 2019 May 9.

Modifiable risk factors for advanced vs. early breast cancer in the French E3N cohort

Lucie Veron  1   2 , Amandine Gelot  1 , Gaelle Gusto  1 , Patrick Arveux  1 , Suzette Delaloge  3 , Marie-Christine Boutron-Ruault  1   2
Affiliations
Observational Study

Modifiable risk factors for advanced vs. early breast cancer in the French E3N cohort

Lucie Veron et al. Int J Cancer. .

Abstract

Advanced breast cancer (BC) is associated with heavier treatments and poorer prognosis than early BC. Despite mammographic screening, advanced BC incidence remains stable. Little is known about risk factors differentially associated with advanced BC. We analyzed factors predicting for postmenopausal advanced vs. early BC in the E3N cohort. E3N has been prospectively following 98,995 French women aged 50-65 years at baseline since 1990. Hazard ratios (HRs) and 95% confidence intervals (CIs) for advanced and early invasive BC were estimated with multivariate Cox competing risk hazard models. With a median follow-up of 15.7 years, 4,941 postmenopausal BC were diagnosed, including 1,878 (38%) advanced BC. Compared to early BC, advanced BC was differentially associated with excess weight (HR 1.39 [95% CI = 1.26-1.53] vs. 1.08 [95% CI = 1.00-1.17], phomogeneity < 0.0001) and living in a rural area (HR 1.14 [95% CI = 1.00-1.31] vs. 0.93 [95% CI = 0.82-1.04], phomogeneity 0.02). Excess weight was the only differential risk factor for advanced BC for hormone-dependent BC and for women compliant with screening recommendations. Previous mammography was associated with reduced advanced BC risk (HR 0.86 [95% CI = 0.73-1.00]) and increased early BC risk (HR 1.36 [95% CI = 1.18-1.56], phomogeneity < 0.0001), but only for hormone-dependent BC. Excess weight appears to be mostly associated with advanced BC, especially hormone-dependent BC. These results add to the evidence for maintaining weight within the recommended limits.

Keywords: advanced breast cancer; cohort; prospective study; risk factors.

PubMed Disclaimer

References

    1. Fact Sheets by Cancer [Internet]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx# [date last accessed September 7, 2018].
    1. Sparano JA, Gray RJ, Makower DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 2018;379:111-21.
    1. Cardoso F, van't Veer LJ, Bogaerts J, et al. 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med 2016;375:717-29.
    1. AJCC - 7th Edition [Internet]. Available from: https://cancerstaging.org/references-tools/quickreferences/documents/bre... [date last accessed September 7, 2018].
    1. Cardoso F, Spence D, Mertz S, et al. Global analysis of advanced/metastatic breast cancer: decade report (2005-2015). Breast 2018;39:131-8.

Publication types

LinkOut - more resources